Standard Biotools (LAB) Gross Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,015.00 |
| Dec 31, 2025 | -4,598.00 |
| Sep 30, 2025 | -367.00 |
| Jun 30, 2025 | 346.00 |
| Mar 31, 2025 | -36,478.00 |
| Dec 31, 2024 | -930.00 |
| Sep 30, 2024 | 268.00 |
| Jun 30, 2024 | -836.00 |
| Mar 31, 2024 | -331.00 |
| Dec 31, 2023 | -1,081.00 |
| Sep 30, 2023 | -1,066.00 |
| Jun 30, 2023 | -225.00 |
| Mar 31, 2023 | -429.00 |
| Dec 31, 2022 | 10,899.00 |
| Sep 30, 2022 | -1,793.00 |
| Jun 30, 2022 | -7,153.00 |
| Mar 31, 2022 | -290.00 |
| Sep 30, 2021 | -4,122.00 |
| Jun 30, 2021 | -3,661.00 |
| Mar 31, 2021 | 3,082.00 |
| Dec 31, 2020 | -9,695.00 |
| Sep 30, 2020 | -4,445.00 |
| Jun 30, 2020 | -5,179.00 |
| Mar 31, 2020 | 35,643.00 |
| Dec 31, 2019 | -4,182.00 |
| Sep 30, 2019 | -4,486.00 |
| Jun 30, 2019 | -945.00 |
| Mar 31, 2019 | -974.00 |
| Dec 31, 2018 | -10,218.00 |
| Sep 30, 2018 | -1,728.00 |
| Jun 30, 2018 | -2,069.00 |
| Mar 31, 2018 | -1,751.00 |
| Dec 31, 2017 | -13,998.00 |
| Sep 30, 2017 | -1,860.00 |
| Jun 30, 2017 | 2,543.00 |
| Mar 31, 2017 | 2,802.00 |
| Dec 31, 2016 | -2,861.00 |
| Sep 30, 2016 | 2,566.00 |
| Jun 30, 2016 | 2,360.00 |
| Mar 31, 2016 | -370.00 |
| Dec 31, 2015 | 12,815.00 |
| Sep 30, 2015 | 58,653.00 |
| Jun 30, 2015 | 3,332.00 |